Hudson Bay Capital Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Hudson Bay Capital Management’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,720,199	Closed	-$513K	–	1060
2023 Q2	$513K	Sell	1,720,199 -49,904	-3%	-$15.1K	﹤0.01%	628
2023 Q1	$765K	Sell	1,770,103 -191,767	-10%	-$147K	0.01%	607
2022 Q4	$2.32M	Sell	1,961,870 -257,933	-12%	-$420K	0.02%	571
2022 Q3	$5.15M	Sell	2,219,803 -885,197	-29%	-$2.32M	0.05%	395
2022 Q2	$6.77M	Hold	3,105,000	–	–	0.05%	310
2022 Q1	$28.4M	Buy	3,105,000 +2,105,000	+211%	+$18.9M	0.38%	41
2021 Q4	$9.92M	Hold	1,000,000	–	–	0.1%	137
2021 Q3	$9.89M	Sell	1,000,000 -3,105,000	-76%	-$30.4M	0.13%	128
2021 Q2	$12.9M	Hold	4,105,000	–	–	0.16%	91
2021 Q1	$12.8M	Buy	+4,105,000	New	+$40.3M	0.16%	90

Hudson Bay Capital Management's GRNA Position: Q3 2023 in Review

Hudson Bay Capital Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 1,720,199 shares — an estimated $513K sold.

Hudson Bay Capital Management first reported a position in GRNA in Q1 2021 and held it in 10 quarters. The position peaked at $28.4M in Q1 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Hudson Bay Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 1,720,199 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $513K.
Hudson Bay Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2021 and held it in 10 quarters.
Hudson Bay Capital Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $28.4M in Q1 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Hudson Bay Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.